Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128924) titled 'Subsequent Medication Use and the Risk of Ketoacidosis in Patients with SGLT2 Inhibitor-Associated Ketosis: A Real-World Cohort Study' on July 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Third Affiliated Hosptial of ChongQing Medical University
Condition:
Type 2 diabetes
Intervention:
Continue SGLT2i group:None
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-06-02
Target Sample Size: Continue SGLT2i group:18;Switch to other antihyperglycemic drugs group:83;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/s...